GlaxoSmithKline PLC
OTC:GLAXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
OTC:GLAXF
|
UK |
|
Rollins Inc
NYSE:ROL
|
US |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
A
|
Avex Inc
F:AX8
|
JP |
|
I
|
Italgas SpA
SWB:I10
|
IT |
|
Helix Energy Solutions Group Inc
NYSE:HLX
|
US |
|
C
|
CACI International Inc
F:CA8A
|
US |
|
Telefonaktiebolaget LM Ericsson
BMV:ERICN
|
SE |
|
Maximus Inc
NYSE:MMS
|
US |
|
Vaxart Inc
NASDAQ:VXRT
|
US |
|
XPS Pensions Group PLC
F:406
|
UK |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
Boyd Gaming Corp
NYSE:BYD
|
US |
|
C
|
Camping World Holdings Inc
F:C83
|
US |
|
A
|
Anheuser Busch Inbev SA
XHAM:1NBA
|
BE |
|
I
|
International Seaways Inc
F:IS5
|
US |
|
S
|
Swatch Group AG
XBER:UHRN
|
CH |
|
G
|
GlaxoSmithKline PLC
XHAM:GS7
|
UK |
|
Montrose Environmental Group Inc
F:5MO
|
US |
Wall St Price Targets
GLAXF Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GLAXF is 29.41 USD with a low forecast of 20.2 USD and a high forecast of 39.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLAXF's stock price target?
Price Target
29.41
USD
According to Wall Street analysts, the average 1-year price target for GLAXF is 29.41 USD with a low forecast of 20.2 USD and a high forecast of 39.7 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.
